Sorrento Therapeutics, Inc.
SRNE$856M
Small CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaSAN DIEGO
Drugs in Pipeline
4
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
SRNE News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
Abivertinib
Covid-19
STI-5656
Covid19
COVI-DROPS
Covid19
STI-6129
Multiple Myeloma
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Abivertinib | Phase 2 | Covid-19 | - | - |
STI-5656 | Phase 2 | Covid19 | - | - |
COVI-DROPS | Phase 2 | Covid19 | - | - |
STI-6129 | Phase 2 | Multiple Myeloma | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply